Oppenheimer & CO Inc Inovio Pharmaceuticals, Inc. Transaction History

Oppenheimer & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.44 - $3.98 $84,019 - $232,221	-58,347 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.97 - $5.2 $101,288 - $177,340	34,104 Added 140.68%	58,347 $209,000
Q4 2021 Feb 02, 2022	BUY	$4.99 - $7.46 $120,972 - $180,852	24,243 New	24,243 $121,000
Q3 2021 Nov 12, 2021	SELL	$7.16 - $9.69 $88,153 - $119,303	-12,312 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$6.23 - $10.03 $76,703 - $123,489	12,312 New	12,312 $114,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.